Adenosine deaminase activity in serum of patients with hepatitis - A useful tool in monitoring clinical status

Journal of Microbiology, Immunology and Infection

Volumn 40, Issue 4, 2007, Pages 288-292

  Kaya, Selçuk ^a,b   Çetin, Emel Sesli ^a   Aridogan, Buket Cicioglu ^a   Arikan, Salih ^a   Demirci, Mustafa ^a  

^a SULEYMAN DEMIREL UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b Istanbul Cad No: 52 Kat: 4/14   (Turkey)

Author keywords

Adenosine deaminase; Hepacivirus; Hepatitis B virus; Viral load

Indexed keywords

ADENOSINE DEAMINASE; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; COLORIMETRY; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; VIRUS LOAD;

ADENOSINE DEAMINASE; ADULT; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; CLINICAL ENZYME TESTS; FEMALE; HEPACIVIRUS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HUMANS; MALE; MIDDLE AGED; VIRAL LOAD;

EID: 35748965047     PISSN: 16841182     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Kane M. Global programme for control of hepatitis B infection. Vaccine. 1995;13(Suppl 1):S47-9.
2. Hepatitis C. Weekly Epidemiology Record. 1997;72:65-9.
3. Lee WM. Hepatitis B virus infection. N Engl J Med 1997;337: 1733-45.
4. Lavanchy D. Hepatitis C: public health strategies. J Hepatol. 1999;31(Suppl 1):146-51.
5. Chen DS. From hepatitis to hepatoma: lessons from type B viral hepatitis. Science. 1993;262:369-70.
6. Williams R. Global challenges in liver disease. Hepatology. 2006;44:521-6.
7. Pawlotsky JM. Hepatitis C virus infection: virus/host interactions. J Viral Hepat. 1998;5(Suppl 1):3-8.
8. Zechini B, Pasquazzi C, Aceti A. Correlation of serum aminotransferases with HCV RNA levels and histological findings in patients with chronic hepatitis C: the role of serum aspartate transaminase in the evaluation of disease progression. Eur J Gastroenterol Hepatol. 2004;16:891-6.
9. Fanning L, Kenny E, Sheehan M, Cannon B, Whelton M, O'Connell J, et al. Viral load and clinicopathological features of chronic hepatitis C (1b) in a homogeneous patient population. Hepatology. 1999;29:904-7.
10. Fox IH, Kelley WN. The role of adenosine and 2′-deoxyadenosine in mammalian cells. Annu Rev Biochem. 1978;47:655-86.
11. Bairoch A. The enzyme data bank in 1995. Nucleic Acids Res. 1996;24:221-2.
12. Sullivan JL, Osborne WR, Wedgewood RJ. Adenosine deaminase activity in lymphocytes. Br J Haematol. 1977;37:157-8.
13. Galanti B, Nardiello S, Russo M, Fiorentino F. Increased lymphocyte adenosine deaminase in typhoid fever. Scand J Infect Dis. 1981;13:47-50.
14. Piras MA, Gakis C, Budroni M, Adreoni G. Immunological studies in Mediterranean spotted fever. Lancet. 1982;1(8283):1249.
15. Gakis G, Calia G, Naitana A, Pirino D, Serru G. Serum adenosine deaminase activity in HIV positive subjects. A hypothesis on the significance of ADA2. Panminerva Med. 1989;31:107-13.
16. Gakis G, Calia GM, Naitana AG, Ortu AR, Contu A. Serum and pleural adenosine deaminase activity. Correct interpretation of the findings. Chest. 1991;99:1555-6.
17. Valls V, Ena J, Roca V, Perez-Oteyza C, Angeles Figueredo M, Enriquez-de-Salamanca R. Significance of adenosine deaminase measurement in sera of patients with HIV-1 infection. AIDS. 1990;4:365-6.
18. Erel O, Kocyigit A, Gurel MS, Bulut V, Seyrek A, Ozdemir Y. Adenosine deaminase activities in sera, lymphocytes and granulocytes in patients with cutaneous leishmaniasis. Mem Inst Oswaldo Cruz. 1998:93:491-4.
19. Ungerer JP, Burger HM, Bissbort SH, Vermaak WJ. Adenosine deaminase isoenzymes in typhoid fever. Eur J Clin Microbiol Infect Dis. 1996;15:510-2.
20. Kobayashi F, Ikeda T, Marumo F, Sato C. Adenosine deaminase isoenzymes in liver disease. Am J Gastroenterol. 1993;88:266-71.
21. Fernández E, Rodrigo L, Riestra S, Carcía S, Gutiérrez F, Ocio G. Adenosine deaminase isoenzymes and neopterin in liver cirrhosis. J Clin Gastroenterol. 2000;30:181-6.
22. Sánchez Rodríguez A, Hueso Pérez J, Rico Sánchez J, Sánchez Fuentes D, Gonzalez JA, Pérez-Sandoval D, et al. Enzymatic activity of serum adenosine deaminase in different liver disorders. An Med Interna. 1989;6:300-4. [In Spanish, English abstract].
23. Nilius R, Neef L, Rath FW, Gatzsche M, Zipprich B. Adenosine deaminase activity - an indicator of inflammation in liver disease. Dtsch Z Verdau Stoffwechselkr. 1987;47:224-9. [In German, English abstract].
24. Barnes CR, Mandell GL, Carper HT, Loung S, Sullivan GW. Adenosine modulation of tumor necrosis factor-alpha-induced neutrophil activation. Biochem Pharmacol. 1995;50:1851-7.
25. Kalkan A, Bulut V, Erel O, Avci S, Bingol NK. Adenosine deaminase and guanosine deaminase activities in sera of patients with viral hepatitis. Mem Inst Oswaldo Cruz. 1999;94:383-6.
26. Nardiello S, Russo M, Pizzella T, Galanti B. Different levels of lymphocyte adenosine deaminase in active and inactive forms of chronic liver disease. J Clin Lab Immunol. 1983;11:177-80.
27. Ito H, Yoshioka K, Ukai K, Watanabe K, Yano M, Ishigami M, et al. The fluctuations of viral load and serum alanine amino-transferase levels in chronic hepatitis C. Hepatol Res. 2004;30:11-7.